Getinge B stock holds steady as 52-week high stays in view
Published on 08/29/2026 at 08:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Getinge B stock (ISIN SE0000202624) traded at SEK245.40 on August 28, 2026, with a 0.16 percent daily gain and a 52-week high of SEK247.30 set on August 28, 2026. The Swedish healthcare equipment group is still being judged through the lens of its latest reported quarter and its place in a defensive hospital supply chain.
Market level
The share price sat just 1.90 kroner below that 52-week peak, a narrow gap that leaves the stock close to its recent ceiling. The move also came with a market backdrop that has kept buyers focused on stable cash-generating names rather than broad multiples expansion.
Latest quarter
Recent market data in the same stock overview points to Getinge's current fiscal 2026 context, with the company being framed against other Swedish healthcare and industrial names. For investors, the important comparison is not hype but the combination of a near-high share price and a business tied to hospitals, surgery, and intensive care.
A separate market snapshot of the Swedish mid-cap context lists Getinge B alongside peers and shows how the share is being positioned against concrete quarterly figures in the wider Nordic market. That same dataset highlights a peer example with Q2 fiscal 2026 revenue of SEK2.96 billion, earnings of SEK99 million, and a 3.34 percent margin, underscoring how current reporting-period numbers remain central to the comparison set.
Business backdrop
Getinge AB (publ) operates in healthcare equipment and services, a category that tends to keep investor attention on order stability, margins, and execution rather than headline growth alone. The company's products are used in hospital workflows where replacement cycles and installed base support matter as much as new demand.
For that reason, the stock often trades on visible operating consistency. A near-52-week-high share price can help, but the next reported quarter will decide whether that valuation backdrop can hold.
Focus product
Getinge's infection-control and critical-care portfolio remains the core product lens for the market, because those categories connect directly to hospital spending and procedure volumes. That gives the stock a relatively steady operating profile even when broader sentiment moves around it.
Price view
Getinge B stock ended the latest session at SEK245.40 as of August 28, 2026. The 52-week high stands at SEK247.30, leaving the shares within SEK1.90 of that level.
Fact box
Company: Getinge AB (publ)
ISIN: SE0000202624
Ticker: GETI-B.ST
Exchange: Nasdaq Stockholm
Price (as of August 28, 2026, close, local time): SEK245.40
Market cap: not stated in the available data
Sector / Industry: Healthcare equipment and services
Index membership: Swedish mid-cap segment
